A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
Read full story at India Latest News: Top National Headlines Today & Breaking News | The Hindu ↗